Prof. Dr. med.; M.Sc. Michael Brändle
Chefarzt
Allgemeine Innere Medizin | Hausarztmedizin und Notfallmedizin, Endokrinologie | Diabetologie | Osteologie | Stoffwechselerkrankungen · Dept. I
Gender dependence of serum soluble Klotho in acromegaly
Sze L, Neidert M, Bernays R, Zwimpfer C, Wiesli P, Haile S, Brändle M, Schmid C. Gender dependence of serum soluble Klotho in acromegaly. Clin Endocrinol (Oxf) 2014; 80:869-73.
10.01.2014Gender dependence of serum soluble Klotho in acromegaly
10.01.2014Clin Endocrinol (Oxf) 2014; 80:869-73
Sze Lisa, Neidert Marian C, Bernays René L, Zwimpfer Cornelia, Wiesli Peter, Haile Sarah, Brändle Michael, Schmid Christoph
Von Myopie zu Hyperopie in drei Wochen – ohne Brillenkorrektur
Brändle M. Von Myopie zu Hyperopie in drei Wochen – ohne Brillenkorrektur. Swiss Medical Forum 2013; 13:758-760.
28.12.2013Von Myopie zu Hyperopie in drei Wochen – ohne Brillenkorrektur
28.12.2013Swiss Medical Forum 2013; 13:758-760
Brändle Michael
Hyperthyreose: Diagnostik und Therapie
Krull I, Brändle M. Hyperthyreose: Diagnostik und Therapie. Swiss Medical Forum 2013; 13:954-960.
28.12.2013Hyperthyreose: Diagnostik und Therapie
28.12.2013Swiss Medical Forum 2013; 13:954-960
Krull Ina, Brändle Michael
Impact of Growth Hormone on Cystatin C
Sze L, Bernays R, Zwimpfer C, Wiesli P, Brändle M, Schmid C. Impact of Growth Hormone on Cystatin C. Nephron Extra 2013; 3:118-124.
20.11.2013Impact of Growth Hormone on Cystatin C
20.11.2013Nephron Extra 2013; 3:118-124
Sze Lisa, Bernays René L, Zwimpfer Cornelia, Wiesli Peter, Brändle Michael, Schmid Christoph
Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study
Christ E, Reubi J, Perren A, Gloor B, Seufert J, Ell P, Stettler C, Fischli S, Clerici T, Brändle M, Caplin M, Nicolas G, Béhé M, Ederer S, Wild D, Forrer F. Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study. Lancet Diabetes Endocrinol 2013; 1:115-22.
25.07.2013Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study
25.07.2013Lancet Diabetes Endocrinol 2013; 1:115-22
Christ Emanuel, Reubi Jean Claude, Perren Aurel, Gloor Beat, Seufert Jochen, Ell Peter J, Stettler Christoph, Fischli Stefan, Clerici Thomas, Brändle Michael, Caplin Martyn E, Nicolas Guillaume, Béhé Martin, Ederer Susanne, Wild Damian, Forrer Flavio
Insulinoma: only in adults?-case reports and literature review
Gozzi Graf T, Brändle M, Clerici T, L'allemand D. Insulinoma: only in adults?-case reports and literature review. Eur J Pediatr 2013; 173:567-74.
21.04.2013Insulinoma: only in adults?-case reports and literature review
21.04.2013Eur J Pediatr 2013; 173:567-74
Gozzi Graf Tiziana, Brändle Michael, Clerici Thomas, L'allemand Dagmar
Diagnostische und therapeutische Aspekte des Vitamin-D-Mangels bei Patienten mit primärem Hyperparathyreoidismus
Gnädinger M, Clerici T, Brändle M, Mellinghoff H. Diagnostische und therapeutische Aspekte des Vitamin-D-Mangels bei Patienten mit primärem Hyperparathyreoidismus. Swiss Medical Forum 2012; 12:659-660.
30.12.2012Diagnostische und therapeutische Aspekte des Vitamin-D-Mangels bei Patienten mit primärem Hyperparathyreoidismus
30.12.2012Swiss Medical Forum 2012; 12:659-660
Gnädinger Markus, Clerici Thomas, Brändle Michael, Mellinghoff H
Post-surgical obesity in 3rd ventricular tumours – new pathophysiological perspectives
Hildebrandt G, Brändle M, Stienen M, Gautschi O, van Leyen K. Post-surgical obesity in 3rd ventricular tumours – new pathophysiological perspectives. Chirurgia 2012; 25:301-310.
01.08.2012Post-surgical obesity in 3rd ventricular tumours – new pathophysiological perspectives
01.08.2012Chirurgia 2012; 25:301-310
Hildebrandt Gerhard, Brändle Michael, Stienen Martin N., Gautschi Oliver, van Leyen Karin
Excessively high soluble Klotho in patients with acromegaly
Sze L, Bernays R, Zwimpfer C, Wiesli P, Brändle M, Schmid C. Excessively high soluble Klotho in patients with acromegaly. J Intern Med 2012; 272:93-7.
23.04.2012Excessively high soluble Klotho in patients with acromegaly
23.04.2012J Intern Med 2012; 272:93-7
Sze Lisa, Bernays R L, Zwimpfer C, Wiesli P, Brändle Michael, Schmid C
Evaluating the Long-Term Cost-Effectiveness of Liraglutide Versus Exenatide BID in Patients With Type 2 Diabetes Who Fail to Improve With Oral Antidiabetic Agents
Valentine W, Palmer A, Lammert M, Langer J, Brändle M. Evaluating the Long-Term Cost-Effectiveness of Liraglutide Versus Exenatide BID in Patients With Type 2 Diabetes Who Fail to Improve With Oral Antidiabetic Agents. Clin Ther 2011; 33:1698-712.
21.10.2011Evaluating the Long-Term Cost-Effectiveness of Liraglutide Versus Exenatide BID in Patients With Type 2 Diabetes Who Fail to Improve With Oral Antidiabetic Agents
21.10.2011Clin Ther 2011; 33:1698-712
Valentine William J, Palmer Andrew J, Lammert Morten, Langer Jakob, Brändle Michael
Regional differences of glycaemic control in patients with type 2 diabetes mellitus in Switzerland: a national cross-sectional survey
Gerber P, Spirk D, Brändle M, Thoenes M, Lehmann R, Keller U. Regional differences of glycaemic control in patients with type 2 diabetes mellitus in Switzerland: a national cross-sectional survey. Swiss Med Wkly 2011; 141:w13218.
07.07.2011Regional differences of glycaemic control in patients with type 2 diabetes mellitus in Switzerland: a national cross-sectional survey
07.07.2011Swiss Med Wkly 2011; 141:w13218
Gerber Philipp Andreas, Spirk David, Brändle Michael, Thoenes Martin, Lehmann Roger, Keller Ulrich
Carbohydrate counting of food
Hegar K, Heiber S, Brändle M, Christ E, Keller U. Carbohydrate counting of food. Swiss Med Wkly 2011; 141:w13224.
07.07.2011Carbohydrate counting of food
07.07.2011Swiss Med Wkly 2011; 141:w13224
Hegar Karin, Heiber Stefanie, Brändle Michael, Christ Emanuel, Keller Ulrich
Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas
Wild D, Ell P, Perren A, Bomanji J, Weber W, Seufert J, Brändle M, Forrer F, Kurzawinski T, Caplin M, Christ E, Reubi J. Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas. J Nucl Med 2011; 52:1073-8.
16.06.2011Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas
16.06.2011J Nucl Med 2011; 52:1073-8
Wild Damian, Ell Peter J, Perren Aurel, Bomanji Jamshed, Weber Wolfgang A, Seufert Jochen, Brändle Michael, Forrer Flavio, Kurzawinski Tom R, Caplin Martyn E, Christ Emanuel, Reubi Jean Claude
Cost-effectiveness of insulin glargine versus NPH insulin for the treatment of Type 2 diabetes mellitus, modeling the interaction between hypoglycemia and glycemic control in Switzerland
Brändle M, Azoulay M, Greiner R. Cost-effectiveness of insulin glargine versus NPH insulin for the treatment of Type 2 diabetes mellitus, modeling the interaction between hypoglycemia and glycemic control in Switzerland. Int J Clin Pharmacol Ther 2011; 49:217-230.
01.03.2011Cost-effectiveness of insulin glargine versus NPH insulin for the treatment of Type 2 diabetes mellitus, modeling the interaction between hypoglycemia and glycemic control in Switzerland
01.03.2011Int J Clin Pharmacol Ther 2011; 49:217-230
Brändle Michael, Azoulay M, Greiner R -A
Diabetes
Brändle M. Diabetes - Patient Selection. In: Textbook of Interventional Cardiology. 6th EditionPhiladelphia: Elsevier Saunders, 2010. ISBN 978-1-4377-2358-8. S. 30-50.
01.01.2011Diabetes
01.01.2011Elsevier Saunders, ISBN 978-1-4377-2358-8
Brändle Michael
Evaluating the cost-effectiveness of self-monitoring of blood glucose in type 2 diabetes patients on oral anti-diabetic agents
Pollock R, Valentine W, Goodall G, Brändle M. Evaluating the cost-effectiveness of self-monitoring of blood glucose in type 2 diabetes patients on oral anti-diabetic agents. Swiss Med Wkly 2010; 140:w13103.
25.10.2010Evaluating the cost-effectiveness of self-monitoring of blood glucose in type 2 diabetes patients on oral anti-diabetic agents
25.10.2010Swiss Med Wkly 2010; 140:w13103
Pollock Richard F, Valentine William J, Goodall Gordon, Brändle Michael
Pituitary apoplexy: re-evaluation of risk factors for bleeding into pituitary adenomas and impact on outcome
Möller-Goede D, Brändle M, Landau K, Bernays R, Schmid C. Pituitary apoplexy: re-evaluation of risk factors for bleeding into pituitary adenomas and impact on outcome. Eur J Endocrinol 2010; 164:37-43.
06.10.2010Pituitary apoplexy: re-evaluation of risk factors for bleeding into pituitary adenomas and impact on outcome
06.10.2010Eur J Endocrinol 2010; 164:37-43
Möller-Goede Diane L, Brändle Michael, Landau Klara, Bernays René L, Schmid Christoph
Randomized controlled trial of bilateral superficial cervical plexus block versus placebo in thyroid surgery
Steffen T, Warschkow R, Brändle M, Tarantino I, Clerici T. Randomized controlled trial of bilateral superficial cervical plexus block versus placebo in thyroid surgery. Br J Surg 2010; 97:1000-6.
01.07.2010Randomized controlled trial of bilateral superficial cervical plexus block versus placebo in thyroid surgery
01.07.2010Br J Surg 2010; 97:1000-6
Steffen Thomas, Warschkow Rene, Brändle Michael, Tarantino Ignazio, Clerici Thomas
Improved glycemic control with the multi-receptor tyrosine kinase inhibitor pazopanib
Böhm S, Hess D, Gillessen Sommer S, Brändle M. Improved glycemic control with the multi-receptor tyrosine kinase inhibitor pazopanib. Diabetes care 2010; 33:e82.
01.06.2010Improved glycemic control with the multi-receptor tyrosine kinase inhibitor pazopanib
01.06.2010Diabetes care 2010; 33:e82
Böhm Steffen, Hess Dagmar, Gillessen Sommer Silke, Brändle Michael
Two patients with an identical novel mutation in the AAAS gene and similar phenotype of triple A (Allgrove) syndrome
Krull I, Maier M, Bärlocher K, Koehler K, Huebner A, Brändle M. Two patients with an identical novel mutation in the AAAS gene and similar phenotype of triple A (Allgrove) syndrome. Exp Clin Endocrinol Diabetes 2010; 118:530-6.
03.03.2010Two patients with an identical novel mutation in the AAAS gene and similar phenotype of triple A (Allgrove) syndrome
03.03.2010Exp Clin Endocrinol Diabetes 2010; 118:530-6
Krull Ina, Maier Margarete, Bärlocher K, Koehler K, Huebner A, Brändle Michael